Drug Testing Locations - New London, PA

Drug Testing in New London, PA

New London, Pennsylvania Statistics

In Chester County, where New London is located, opioid overdoses accounted for over 100 deaths annually in recent years.

Chester County reports a 15% increase in drug-related emergency room visits in the past five years.

Approximately 7% of adults in New London have reported illicit drug use in the past month.

Prescription drug misuse in Chester County accounted for approximately 40% of drug abuse cases.

In Chester County, programs have helped reduce underage drinking and drug use by 10% in recent years.

Over 20% of teenagers in Chester County have admitted to trying marijuana at least once by the age of 18.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New London, PA & Drug Testing Policies

Employers in New London, PA, like those across Chester County, implement drug testing policies to maintain safe and productive workplaces. Many companies adhere to the guidelines provided by the SAMHSA Workplace Programs, which outline best practices for drug testing in professional environments.

Some employers use random drug testing as a deterrent for substance use among employees, while others may conduct pre-employment testing or in cases of workplace incidents. Chester County also provides support for employers through the Chester County Economic Development Council, which advises on effective drug policies and employee assistance programs.

Government Efforts with Drug Problems in New London, PA

The government of Chester County, where New London is situated, has been actively working to combat drug issues through various initiatives. The Chester County Drug and Alcohol Services offers programs aimed at prevention, treatment, and recovery support for residents struggling with substance abuse.

State-level efforts include the Pennsylvania Department of Health Opioid Response Program, which provides resources and support for those affected by the opioid crisis. These efforts are complemented by federal initiatives from the Substance Abuse and Mental Health Services Administration (SAMHSA), aiming to reduce drug addiction and its impacts nationwide.

Local Drug Busts & News in New London, PA

Local law enforcement in New London, PA, has been actively involved in drug bust operations to curb the rising drug problem. Recent efforts in Chester County have led to significant busts, such as a large marijuana distribution ring that was dismantled by the county's drug task force.

Community awareness events and workshops are also held regularly, focusing on the dangers of drug use and available resources. These include collaborations between local law enforcement and community organizations aimed at educating residents and preventing drug abuse in Chester County.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New London, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Brandywine Counseling & Community Services

Mental Health America

The Council of Southeastern Pennsylvania

Recovery Centers of America

Addiction Center - Pennsylvania Rehabs

Liberty Mid-Atlantic High Intensity Drug Trafficking Area

Caron Treatment Centers

Chester County Health Department

Valley Forge Medical Center & Hospital

Network of Care for Behavioral Health

Drug Testing Near New London, PA

Willowdale, PA

Kennett Square, PA

Five Points, PA

Cochranville, PA

Kaolin, PA

Toughkenamon, PA

Chatham, PA

Landenberg, PA

Oxford, PA

West Grove, PA

Lincoln University, PA

Kemblesville, PA

Jennersville, PA

Hickory Hill, PA

Kelton, PA

Frequently Asked Questions

Customer Reviews